These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25107568)

  • 1. Anticancer activity of VDR-coregulator inhibitor PS121912.
    Sidhu PS; Teske K; Feleke B; Yuan NY; Guthrie ML; Fernstrum GB; Vyas ND; Han L; Preston J; Bogart JW; Silvaggi NR; Cook JM; Singh RK; Bikle DD; Arnold LA
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):787-98. PubMed ID: 25107568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel Vitamin D Receptor-Coactivator Inhibitors.
    Sidhu PS; Nassif N; McCallum MM; Teske K; Feleke B; Yuan NY; Nandhikonda P; Cook JM; Singh RK; Bikle DD; Arnold LA
    ACS Med Chem Lett; 2014 Feb; 5(2):199-204. PubMed ID: 24799995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
    Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
    Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
    Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
    Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
    Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
    García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
    PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors for the Vitamin D Receptor-Coregulator Interaction.
    Teske KA; Yu O; Arnold LA
    Vitam Horm; 2016; 100():45-82. PubMed ID: 26827948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D
    Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
    Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells.
    Amano Y; Cho Y; Matsunawa M; Komiyama K; Makishima M
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):144-51. PubMed ID: 19429444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection.
    Gaschott T; Stein J
    Recent Results Cancer Res; 2003; 164():247-57. PubMed ID: 12899527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
    Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
    J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
    Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
    J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.
    Zhang Z; Kovalenko P; Cui M; Desmet M; Clinton SK; Fleet JC
    J Cell Physiol; 2010 Aug; 224(2):433-42. PubMed ID: 20432439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.
    Zhuang SH; Schwartz GG; Cameron D; Burnstein KL
    Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
    Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
    Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.